Autologous Bone Marrow Transplantation in Acute Lymphoblastic Leukemia—Mafosfamide Italian Study Group

  • V. Rizzoli
  • L. Mangoni
  • A. M. Carella
  • G. Torlontano
  • M. Aglietta
  • L. Resegotti
  • E. Madon
  • R. Mozzana
  • A. Porcellini
  • P. Coleselli
Conference paper
Part of the Experimental Hematology Today—1987 book series (HEMATOLOGY, volume 1987)

Abstract

Clinical experience demonstrates that a number of human tumors show a high response rate to aggressive chemotherapy regimens (1–2).

Keywords

Toxicity Lymphoma DMSO Leukemia Aldehyde 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Herzig GP (1981): Autologous marrow transplantation in cancer therapy. Prog. Hematol. 12:1PubMedGoogle Scholar
  2. 2.
    Gehan EA (1984): Dose-response relationship in clinical oncology. Cancer, 54 (suppl.): 1204PubMedCrossRefGoogle Scholar
  3. 3.
    Barret AJ, Kendra JR, Lucas CF, Joss DV, Joshi R, Desai M, Hugh Jones K, Phillips RH, Rogers TR, Tabara Z, Williamson S, Hobbs J (1982): Bone marrow transplantation for acute lymphoblastic leukemia. Br. J. Haematol. 52:181CrossRefGoogle Scholar
  4. 4.
    Thomas ED, Buckner CD, Banaji M (1977). One hundred patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation. Blood 49:511PubMedGoogle Scholar
  5. 5.
    Hagenbeeck A, Martens ACM (1984): Toxicity of asta Z 7557 (INN-mafosfamide) to normal and leukemic stem cells: Implications for autologous bone marrow transplantation. Invest, new drugs 2:237Google Scholar
  6. 6.
    Bortin MM, Gale RP, Kay HEM, Rimm AA (1983): Bone marrow transplantation for acute myelogenous leukemia. JAMA 249:1166PubMedCrossRefGoogle Scholar
  7. 7.
    Gorin NC, Aegerter P, Parlier Y, for the working party on autologous bone marrow transplantation of the European Bone Marrow Transplantation Group (1985): Autologous bone marrow transplantation for acute leukemia in remission: Second European Survey. Exp. Hematol. B, suppl. 17:18Google Scholar
  8. 8.
    Mandelli F (1986): Autologous bone marrow transplantation (ABMT) in leukemia. Proc. of third int. symp. ABMT, Houston, in press.Google Scholar
  9. 9.
    Marmont AM, Carella AM (1986): Autologous bone marrow transplantation in haematologic malignancies. Haematologica, 71:1PubMedGoogle Scholar
  10. 10.
    Treleaven JG, Kemshead JT (1985): Removal of tumor cells from bone marrow: An evaluation of the available techniques. Haematol. Oncol., 3:6511CrossRefGoogle Scholar
  11. 11.
    Bast RC JR, DeFabritiis P, Bregni M, Raso V, Reynolds C, Lipton JM, Grenberger JS, Nadler LM, Sallan SE, Ritz J (1984): Removal of malignant cells from human bone marrow using monoclonal antibodies and complement. In: Dicke K, Spitzer G, Zander A (eds): Proc. First Int. Symp. on Autologous Bone Marrow Transplantation, p. 373Google Scholar
  12. 12.
    Bast RC, Ritz J, Lipton JM, Feeney M, Sallan SC, Nathan DG, Schlossman SF (1983): Elimination of leukemic cells from human bone marrow using monoclonal antibody and complement. Cancer Res. 43:1389PubMedGoogle Scholar
  13. 13.
    Hagenbeek A, Martens ACM: Toxicity of ASTA-Z 7557 (INN mafosfamide) to normal and leukemic stem cells: Implications for autologous bone marrow transplantation. Investigational New Drugs, 2:237Google Scholar
  14. 14.
    Sharkis SJ, Santos GW, Colvin M (1980): Elimination of acute myelogenous leukemic cells from marrow and tumor suspensions in the rat with 4-hydroperoxycyclophosphamide. Blood 55:521PubMedGoogle Scholar
  15. 15.
    Porcellini A, Manna A, Sparaventi G, Talevi N, Rizzoli V (1983): The selective effect of 4-hydroperoxycyclophosphamide. (ASTA-Z) on pluripotent and committed stem cell compartment in mice. Exp. Hematol. 11 (suppl.14): 133aGoogle Scholar
  16. 16.
    Zeller WJ, Berger MR, Matys R, Schmacher J (1984): Antineoplastic of ASTA Z 7557 (INN-mafosfamide) in transplant and autochthonous experimental rodent tumors. Investigational New Drugs 2:175PubMedCrossRefGoogle Scholar
  17. 17.
    Hagenbeek A, Martens ACM (1985): Preclinical studies on detection of minimal residual disease in acute leukemia. In: Dicke DA, Spitzer G Zander AR (eds): Proc. of the First Int. Symp. of Autologous Bone Marrow Transplantation, p.329Google Scholar
  18. 18.
    Philip I, Favrot MC, Philip T (1985): Detection of Burkitt’s cells in remission marrow by a cell culture monitoring system: Implications for autologous bone marrow transplantation. In: Dicke KA, Zander AD (eds): Proc. of the First Int. Symp. of Autologous Bone Marrow Transplantation, p.341Google Scholar
  19. 19.
    Reynolds CP, Black AT, Woody JN (1985): Use of Hoechst 3342 for sensitive detection of viable cells seeded into bone marrow. In: Dicke KA, Spitzer G, Zander R (eds): Proc. of the First Int. Symp. of Autologous Bone Marrow Transplantation, 365Google Scholar
  20. 20.
    Douay L (1985): Cyclophosphamide derivatives for in vitro cleansing of leukemic bone marrow. Blood transfusion and immunohaematology, Tome 27, 5:427Google Scholar
  21. 21.
    Defabritiis P, Bregni M, Lipton J, Greenberger JS, Nadler LM, Rochstein L, Korbling M, Ritz J, Bast RC, Jr. (1985): Elimination of clonogenic Burkitt’s lymphoma cells from human bone marrow using 4-hydroperoxycyclophosphamide in combination with monoclonal antibodies and complement. Blood 65:1064Google Scholar
  22. 22.
    Santos GW, Kaiser H (1984): In vitro chemotherapy as a prelude to autologous marrow transplantation in hematology malignancy. In: Lowemberg B, Hagenbeek A (eds): Minimal Residual Disease in Acute Leukemia, Boston, Martinus Nijhoff, Ed. 165Google Scholar
  23. 23.
    Rizzoli V, Mangoni L, Degliantoni G, Caramatti C, Costi D, Quaini P (1985): Autologous bone marrow transplantation in acute leukemia and lymphoma. Dicke KA, Spritzer G, Zander AR (eds): Proc. of the First Int. Symp. of Autologous Bone Marrow Transpl., 45Google Scholar
  24. 24.
    Rizzoli V, Mangoni L, Degliantoni G, Caramatti C, Costi D, Craviotto L (1985): Autologous bone marrow transplantation for acute leukemia in remission. Parma experience. Int. J. of Cell Cloning, 3:4, 246Google Scholar
  25. 25.
    Armitage J (1986) Report of an international cooperative study: Bone marrow autotransplantation in man. The Lancet, 960Google Scholar
  26. 26.
    Yeager AM, Kaizer H, Santos GW, et al (1986): Autologous bone marrow transplantation in patients with acute nonlymphocytic leukemia, using ex vivo marrow treatment with 4-hydroperoxycyclophosphamide. New Engl. Journal of Medicine, 3:141CrossRefGoogle Scholar
  27. 27.
    Tura S (1983): Simposio sull’autotrapianto di midollo osseo. Haematologica 6 (suppl.1): 25Google Scholar
  28. 28.
    Carella AM, Santini G, Santoro A, et al (1985): Massive chemotherapy with non-frozen autologous bone marrow transplantation in 13 cases of refractory Hodgkin’s disease. Eur. J. cancer clin. oncol. 5:607-13CrossRefGoogle Scholar
  29. 29.
    Gordon MY, Hibbin JA, Kearney V, Gordon-Smith EC, Goldman JM (1985): Colony formation by primitive haemopoietic progenitors in cocultures of bone marrow cells and stromal cells. Br. J. Haematol. 60:129PubMedCrossRefGoogle Scholar
  30. 30.
    Siena S, Castro-Malaspina H, Gulati SC, et al (1985): Effects of in vitro purging with 4-hydroperoxycyclophosphamide on the hematopoietic and microenvironmental elements of human bone marrow. Blood 65:655PubMedGoogle Scholar
  31. 31.
    Degliantoni G, Mangoni L, Rizzoli V (1986): Normal blast colony formation: An in vitro tool for monitoring human bone marrow purging. Bone Marrow Transpl., 1:209Google Scholar
  32. 32.
    Hilton J, Colvin M (1984): The role of aldehyde dehydrogenase activity in cylophosphamide sensitivity of hematopoietic and leukemic cell populations. Proc. of the Am. Assoc, of Cancer Research, 25:1343 (abstr)Google Scholar
  33. 33.
    Kaplan EL, Meier P (1958): Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc. 53:45734.CrossRefGoogle Scholar
  34. 34.
    Rizzoli V, Mangoni L, Porcellini A, Carelli AM, Alessandrino EP, Aglietta M, Torlontano G, Coleselli P, Mozzana A, Madon E (1986): Autologous Bone Marrow Transplantation for acute lymphocytic leukemia. In: Proc. of Third Int. Symp. on Autologous Bone Marrow Transplantation (in press)Google Scholar
  35. 35.
    Rizzoli V, Mangoni L, Degliantoni G, Porellini A, Carella AM, Alessandrino EP, Mozzana A, Aglietta M, Coleselli P, Torlontano G, Italian Cooperative Group (1986): Mafosfamide bone marrow purging autologous transplantation in acute leukemia. Acta Hematologica (in press)Google Scholar
  36. 36.
    Mangoni L, Porcellini A, Carella AM, Alessandrino EP, Mozzana A, Aglietta M, Coleselli P, Torlontano G, Rizzoli V Italian Cooperative Group (1986): Autologous bone marrow transplantation in acute leukemia using marrow treated with mafosfamide. Blood, 68 (suppl.1):5, 276aGoogle Scholar
  37. 37.
    Gorin NC, Aegerter P, for the Working Party on Autologous Bone Marrow Transplantation of the European Bone Marrow Transplantion Group (1987): Autologous bone marrow transplantation for acute leukemia in remission: 4th European Bone Marrow Transplantation Group Survey. Bone Marrow Transplantation 2 (suppl.#1): 320Google Scholar
  38. 38.
    Gorin NC, Herve P, Aegerter P, Goldstone A, Linch D, Maraninchi D, Burnett A, Helbig W, Meloni G, Verdonck LF, De Witte T, Rizzoli V, Carella A, Parlier Y, Auvert B, Goldman J, for the Working Party on Autologous Bone Marrow Transplantation of the European Bone Marrow Transplantation Group (1986): Autologous bone marrow transplantation for acute leukemia in remission. Br. J. of Hematol., 64:385CrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • V. Rizzoli
  • L. Mangoni
  • A. M. Carella
  • G. Torlontano
  • M. Aglietta
  • L. Resegotti
  • E. Madon
  • R. Mozzana
  • A. Porcellini
  • P. Coleselli

There are no affiliations available

Personalised recommendations